Pittsburgh federal grand jury indicts 2 men in separate fentanyl sales accusations
A federal grand jury at Pittsburgh on Tuesday has separately indicted two men for federal drug and other offenses.
In one indictment, Romone Barnes, 32, of Washington, Washington County, is accused of violating drug and gun laws.
According to the indictment, Barnes distributed an unspecified quantity of fentanyl on June 26, 2017, and possessed with intent to distribute a quantity of methoxyacetyl fentanyl a month later.
He also is charged with possessing a .380-caliber Ruger semi-automatic pistol and ammunition despite being felon.
U.S. Attorney Scott Brady said Barnes has several prior felony drug convictions and cannot legally have guns or ammunition.
Assistant U.S. Attorney Jerome A. Moschetta is prosecuting this case on behalf of the government.
Task Force Officers with Pennsylvania State Police and the Washington County District Attorney’s Office Drug Task Force conducted the investigation leading to the indictment.
According to federal records, Barnes’ arraignment hearing is scheduled for next Wednesday in Pittsburgh.
In a second unrelated indictment, Arrmon Davon Hagans, 38, formerly of Homestead, was accused Tuesday violating federal drug law.
According to the indictment, on March 23 , Hagans possessed with the intent to distribute quantities of para-fluoroisobutyryl fentanyl, heroin, fentanyl and cocaine.
The government is seeking to confiscate $3,770 Hagans had on him when arrested.
An arraignment date wasn’t announced.
The FBI and the Western District of Pennsylvania Opioid Task Force conducted the investigation leading to the indictment in this case.
The task force includes FBI special agents and state and local officers, including officers from Pittsburgh, Allegheny County sheriff’s, Allegheny County police, Port Authority police, Munhall police, West Mifflin police, Stowe Township police, McKees Rocks police, and state Attorney General’s Office.
Chuck Biedka is a Tribune-Review staff writer. You can contact Chuck at 724-226-4711, [email protected] or via Twitter @ChuckBiedka.